1. Home
  2. WYNN vs MEDP Comparison

WYNN vs MEDP Comparison

Compare WYNN & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wynn Resorts Limited

WYNN

Wynn Resorts Limited

HOLD

Current Price

$102.17

Market Cap

11.2B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$422.73

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYNN
MEDP
Founded
2002
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
11.7B
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
WYNN
MEDP
Price
$102.17
$422.73
Analyst Decision
Strong Buy
Hold
Analyst Count
15
12
Target Price
$142.73
$473.17
AVG Volume (30 Days)
1.2M
449.8K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
0.96%
N/A
EPS Growth
N/A
20.98
EPS
1.04
4.28
Revenue
$6,717,660,000.00
N/A
Revenue This Year
$6.49
$13.19
Revenue Next Year
$4.58
$7.75
P/E Ratio
$34.05
$100.52
Revenue Growth
10.67
N/A
52 Week Low
$82.63
$284.48
52 Week High
$134.72
$628.92

Technical Indicators

Market Signals
Indicator
WYNN
MEDP
Relative Strength Index (RSI) 42.81 39.63
Support Level $96.26 $382.68
Resistance Level $106.27 $477.04
Average True Range (ATR) 3.16 16.56
MACD -0.27 -2.21
Stochastic Oscillator 22.60 31.48

Price Performance

Historical Comparison
WYNN
MEDP

About WYNN Wynn Resorts Limited

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company received 49% and 51% of its 2025 prepandemic EBITDA from Macao and the US, respectively.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: